Advertisement
U.S. markets closed

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
244.89-1.91 (-0.77%)
At close: 04:00PM EST
244.11 -0.78 (-0.32%)
After hours: 04:53PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 31.83B
Enterprise Value 30.35B
Trailing P/E N/A
Forward P/E 909.09
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)14.94
Price/Book (mrq)983.88
Enterprise Value/Revenue 14.49
Enterprise Value/EBITDA 204.85

Trading Information

Stock Price History

Beta (5Y Monthly) 0.39
52-Week Change 351.49%
S&P500 52-Week Change 330.47%
52 Week High 3304.39
52 Week Low 3141.98
50-Day Moving Average 3273.53
200-Day Moving Average 3211.89

Share Statistics

Avg Vol (3 month) 3862.1k
Avg Vol (10 day) 31M
Shares Outstanding 5128.98M
Implied Shares Outstanding 6128.98M
Float 8128.44M
% Held by Insiders 10.42%
% Held by Institutions 198.00%
Shares Short (Oct 31, 2024) 43.7M
Short Ratio (Oct 31, 2024) 44.6
Short % of Float (Oct 31, 2024) 43.30%
Short % of Shares Outstanding (Oct 31, 2024) 42.87%
Shares Short (prior month Sep 30, 2024) 44.51M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Sep 30, 2024

Profitability

Profit Margin -15.86%
Operating Margin (ttm)-15.35%

Management Effectiveness

Return on Assets (ttm)-2.92%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)2.09B
Revenue Per Share (ttm)16.52
Quarterly Revenue Growth (yoy)-33.30%
Gross Profit (ttm)N/A
EBITDA -132.15M
Net Income Avi to Common (ttm)-332.26M
Diluted EPS (ttm)-2.62
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.78B
Total Cash Per Share (mrq)21.56
Total Debt (mrq)2.73B
Total Debt/Equity (mrq)8,426.14%
Current Ratio (mrq)2.75
Book Value Per Share (mrq)0.25

Cash Flow Statement

Operating Cash Flow (ttm)56.55M
Levered Free Cash Flow (ttm)309.57M